These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7027430)

  • 1. Comparison of serum salicylate levels and gastro-intestinal blood loss between salsalate (Disalcid)and other forms of salicylates.
    Mielants H; Veys EM; Verbruggen G; Schelstraete
    Scand J Rheumatol; 1981; 10(3):169-73. PubMed ID: 7027430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salicylate-induced occult gastrointestinal blood loss: comparison between different oral and parenteral forms of acetylsalicylates and salicylates.
    Mielants H; Veys EM; Verbruggen G; Schelstraete K
    Clin Rheumatol; 1984 Mar; 3(1):47-54. PubMed ID: 6331971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration.
    Mielants H; Verbruggen G; Schelstraete K; Veys EM
    J Rheumatol; 1979; 6(2):210-8. PubMed ID: 313448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal blood loss and plasma salicylate study of salicylsalicylic acid and aspirin.
    Cohen A
    J Clin Pharmacol; 1979 Apr; 19(4):242-7. PubMed ID: 312297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
    Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
    Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salicylsalicylic acid causes less gastroduodenal mucosal damage than enteric-coated aspirin. An endoscopic comparison.
    Scheiman JM; Behler EM; Berardi RR; Elta GH
    Dig Dis Sci; 1989 Feb; 34(2):229-32. PubMed ID: 2914543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal blood loss from aspirin and sodium salicylate tablets in man.
    Leonards JR; Levy G
    Clin Pharmacol Ther; 1973; 14(1):62-6. PubMed ID: 4539495
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of salsalate and aspirin in osteoarthrosis of the hip or knee.
    Liyanage SP; Tambar PK
    Curr Med Res Opin; 1978; 5(6):450-3. PubMed ID: 350497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroduodenal mucosal damage with salsalate versus aspirin: results of experimental models and endoscopic studies in humans.
    Scheiman JM; Elta GH
    Semin Arthritis Rheum; 1990 Oct; 20(2):121-7. PubMed ID: 2123561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of plasma salicylate levels to pain relief with two different salicylates.
    Hicklin JA
    Curr Med Res Opin; 1978; 5(7):572-9. PubMed ID: 359253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans.
    Morris HG; Sherman NA; McQuain C; Goldlust MB; Chang SF; Harrison LI
    Ther Drug Monit; 1985; 7(4):435-8. PubMed ID: 3866409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of salsalate and aspirin on mucosal injury and gastroduodenal mucosal prostaglandins.
    Cryer B; Goldschmiedt M; Redfern JS; Feldman M
    Gastroenterology; 1990 Dec; 99(6):1616-21. PubMed ID: 2227277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of intravenous aspirin to increase gastrointestinal blood loss.
    Cooke AR; Goulston K
    Br Med J; 1969 Aug; 3(5666):330-2. PubMed ID: 5306445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylates in the management of rheumatoid arthritis.
    Pinals RS
    Mod Treat; 1971 Nov; 8(4):796-806. PubMed ID: 5316723
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effects of aspirin and enteric-coated aspirin on loss of chromium 51-labeled erythrocytes from the gastrointestinal tract.
    Robbins DC; Schwartz RS; Kutny K; Vallejo G; Horton ES; Cotter JM
    Clin Ther; 1984; 6(4):461-6. PubMed ID: 6331883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salsalate and salicylate binding to and their displacement of thyroxine from thyroxine-binding globulin, transthyrin, and albumin.
    Wang R; Nelson JC; Wilcox RB
    Thyroid; 1999 Apr; 9(4):359-64. PubMed ID: 10319941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin.
    Ali M; McDonald JW; Thiessen JJ; Coates PE
    Stroke; 1980; 11(1):9-13. PubMed ID: 7355437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.
    Hawthorne AB; Mahida YR; Cole AT; Hawkey CJ
    Br J Clin Pharmacol; 1991 Jul; 32(1):77-83. PubMed ID: 1888645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal blood loss after diflunisal and after aspirin: effect of ethanol.
    DeSchepper PJ; Tjandramaga TB; De Roo M; Verhaest L; Daurio C; Steelman SL; Tempero KF
    Clin Pharmacol Ther; 1978 Jun; 23(6):669-76. PubMed ID: 348379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.